Integrated hepatic single-cell RNA sequencing and untargeted metabolomics reveals the immune and metabolic modulation of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced pneumonia

Although Qing-Fei-Pai-Du decoction (QFPDD) is extensively used clinically to treat COVID-19 patients, the mechanism by which it modulates the immunological and metabolic functions of liver tissue remains unknown. The purpose of this study is to investigate the mechanism of action of QFPDD in the tre...

Full description

Saved in:
Bibliographic Details
Published in:Phytomedicine (Stuttgart) 2022-03, Vol.97, p.153922-153922, Article 153922
Main Authors: Tian, Saisai, Zheng, Ningning, Zu, Xianpeng, Wu, Gaosong, Zhong, Jing, Zhang, Jinbo, Sheng, Lili, Liu, Wei, Wang, Chaoran, Ge, Guangbo, Han, Jingyan, Zhao, Jing, Li, Houkai, Zhang, Weidong
Format: Article
Language:English
Subjects:
Animals
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Cold-damp environment
Coronavirus disease 2019
COVID-19 Drug Treatment
Drugs, Chinese Herbal - therapeutic use
Humans
Liver
Metabolomics
Mice
Mice, Inbred BALB C
Original
Qing-Fei-Pai-Du decoction
Sequence Analysis, RNA
Single-Cell Analysis
Single-cell RNA sequencing
Untargeted metabolomics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although Qing-Fei-Pai-Du decoction (QFPDD) is extensively used clinically to treat COVID-19 patients, the mechanism by which it modulates the immunological and metabolic functions of liver tissue remains unknown. The purpose of this study is to investigate the mechanism of action of QFPDD in the treatment of mice with coronavirus-induced pneumonia by combining integrated hepatic single-cell RNA sequencing and untargeted metabolomics. We developed a human coronavirus pneumonia model in BALB/c mice by infecting them with human coronavirus HCoV-229E with stimulating them with cold-damp environment. We initially assessed the status of inflammation and immunity in model mice treated with or without QFPDD by detecting peripheral blood lymphocytes and inflammatory cytokines. Then, single-cell RNA sequencing and untargeted metabolomics were performed on mouse liver tissue. HCoV-229E infection in combination with exposure to a cold-damp environment significantly decreased the percentage of peripheral blood lymphocytes (CD4+ and CD8+ T cells, B cells) in mice, which was enhanced by QFPDD therapy. Meanwhile, the levels of inflammatory cytokines such as IL-6, TNF-α, and IFN-γ were significantly increased in mouse models but significantly decreased by QFPDD treatment. Single-cell RNA sequencing analysis showed that QFPDD could attenuate disease-associated alterations in gene expression, core transcriptional regulatory networks, and cell-type composition. Computational predictions indicated that QFPDD rectified the observed aberrant patterns of cell-cell communication. Additionally, the metabolic profiles of liver tissue in the Model group were distinct from mice in the Control group, and QFPDD significantly regulated hepatic purine metabolism. To the best of our knowledge, this study is the first to integrate hepatic single-cell RNA sequencing and untargeted metabolomics into a TCM formula and these valuable findings indicate that QFPDD can improve immune function and reduce liver injury and inflammation. [Display omitted]
ISSN:0944-7113
1618-095X
1618-095X
DOI:10.1016/j.phymed.2021.153922